These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Interleukin-1 in human skin: dysregulation in psoriasis. Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Taylor RS; Voorhees JJ; Fisher G J Invest Dermatol; 1990 Nov; 95(5 Suppl):24S-26S. PubMed ID: 16788624 [TBL] [Abstract][Full Text] [Related]
24. Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes. Gruaz-Chatellard D; Baumberger C; Saurat JH; Dayer JM FEBS Lett; 1991 Dec; 294(1-2):137-40. PubMed ID: 1720743 [TBL] [Abstract][Full Text] [Related]
25. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression. Debets R; Hegmans JP; Buurman WA; Benner R; Prens EP Cytokine; 1996 Jan; 8(1):80-8. PubMed ID: 8742070 [TBL] [Abstract][Full Text] [Related]
26. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids. Gruaz D; Didierjean L; Grassi J; Frobert Y; Dayer JM; Saurat JH Dermatologica; 1989; 179(4):202-6. PubMed ID: 2695356 [TBL] [Abstract][Full Text] [Related]
27. Detection of inflammatory cytokines in psoriatic skin. Yoshinaga Y; Higaki M; Terajima S; Ohkubo E; Nogita T; Miyasaka N; Kawashima M Arch Dermatol Res; 1995; 287(2):158-64. PubMed ID: 7763087 [TBL] [Abstract][Full Text] [Related]
28. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Terui T; Hirao T; Sato Y; Uesugi T; Honda M; Iguchi M; Matsumura N; Kudoh K; Aiba S; Tagami H Exp Dermatol; 1998 Dec; 7(6):327-34. PubMed ID: 9858135 [TBL] [Abstract][Full Text] [Related]
29. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha. Ogilvie AL; Lüftl M; Antoni C; Schuler G; Kalden JR; Lorenz HM Int J Immunopathol Pharmacol; 2006; 19(2):271-8. PubMed ID: 16831294 [TBL] [Abstract][Full Text] [Related]
30. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin. Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612 [TBL] [Abstract][Full Text] [Related]
32. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions. Companjen A; van der Wel L; van der Fits L; Laman J; Prens E Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445 [TBL] [Abstract][Full Text] [Related]
33. Altered binding of Ulex europaeus I lectin to psoriatic epidermis. Kariniemi AL; Holthöfer H; Miettinen A; Virtanen I Br J Dermatol; 1983 Nov; 109(5):523-9. PubMed ID: 6357263 [TBL] [Abstract][Full Text] [Related]
34. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis. Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487 [TBL] [Abstract][Full Text] [Related]
35. Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets. Téllez N; Montolio M; Biarnés M; Castaño E; Soler J; Montanya E Gene Ther; 2005 Jan; 12(2):120-8. PubMed ID: 15578044 [TBL] [Abstract][Full Text] [Related]
36. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599 [TBL] [Abstract][Full Text] [Related]
37. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine. Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379 [TBL] [Abstract][Full Text] [Related]